What is Ozempic and How Does It Work for Weight Loss?

Last reviewed: June 19, 2026

Last updated: June 19, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Ozempic contains semaglutide, a medication originally developed for type 2 diabetes that has become widely used for weight management. Clinical trials show semaglutide users lose an average of 15–22% of body weight over 68 weeks. Understanding how this medication works helps you make an informed decision about whether it may fit your health goals.

How Semaglutide Works in Your Body

Semaglutide mimics glucagon-like peptide-1 (GLP-1), a natural hormone your gut releases after eating. When semaglutide binds to GLP-1 receptors in your brain, it activates regions that control hunger and satiety signals. This action reduces your appetite, slows how quickly your stomach empties, and increases feelings of fullness—all three changes working together to lower calorie intake without willpower alone.

The medication also improves how your body processes blood sugar, which can reduce energy crashes and cravings. Many patients report that food becomes less psychologically rewarding when taking semaglutide, making it easier to stick to smaller portions. These effects typically begin within days of starting treatment and build over the first 4–8 weeks as your dose increases.

Semaglutide Weight Loss Results and Clinical Evidence

The STEP trials, large randomized controlled studies, demonstrated that participants on semaglutide lost significantly more weight than those on placebo. After 68 weeks, semaglutide users achieved average weight loss of 15–22% of starting body weight, compared to 2–3% in the placebo group. Results were consistent across different body weights and metabolic backgrounds, suggesting semaglutide's effectiveness applies to a broad patient population.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Ozempic or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Compounded Semaglutide vs. Brand-Name Ozempic

Ozempic is the brand-name form of semaglutide manufactured by Novo Nordisk, but compounded semaglutide from licensed 503A pharmacies contains the identical active ingredient. PlexusDx partners with licensed 503A compounding pharmacies to prepare semaglutide injections, ensuring pharmaceutical-grade quality and potency. Compounded semaglutide is not FDA-approved as a brand product, but the underlying compound is well-established and studied.

The primary advantages of compounded semaglutide are cost and access: PlexusDx offers it at $189/mo month-to-month, or from $149/mo on the 6-month plan without requiring insurance, membership fees, or insurance approvals. Patients in all 50 states can access treatment, and HSA/FSA funds cover the cost. Your dose may need to go up as you progress through treatment. Your price won't—it remains flat regardless of dose level.

Getting Started with Semaglutide at PlexusDx

PlexusDx begins with a health assessment to confirm semaglutide is appropriate for you. Once approved, you receive injectable semaglutide shipped directly to your home with clear instructions for weekly self-injection. Most patients start at 0.25 mg weekly and increase every 4 weeks until reaching an effective dose, typically between 1 mg and 2.4 mg per week.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Ozempic or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How quickly will I see weight loss results from semaglutide?

Most patients notice reduced hunger within 3–7 days and begin losing weight within 2–4 weeks. Average weekly loss during months 2–6 is 1–2 pounds, with results continuing through month 12. PlexusDx tracks your progress through ongoing clinical support to ensure your dose is optimized for your individual response.

What is the difference between Ozempic and semaglutide?

Ozempic is the brand name; semaglutide is the active ingredient inside it. PlexusDx offers compounded semaglutide prepared by licensed 503A pharmacies, delivering the same active compound as Ozempic but at a lower cost and with nationwide availability. Compounded semaglutide is not FDA-approved as a brand product, but semaglutide itself is a well-established, clinically studied medication.

Does PlexusDx require insurance to get semaglutide?

No. PlexusDx serves all 50 states with no insurance requirement, no membership fee, and no waiting for insurance approval. Compounded semaglutide is $189 per month month-to-month, or from $149/mo on the 6-month plan and is HSA/FSA eligible. Your dose may increase over time, but your monthly price remains flat.

What are the common side effects of semaglutide?

Nausea is the most common side effect, especially during the first 1–2 weeks and after dose increases; it usually resolves within days to weeks. Other potential effects include constipation, vomiting, fatigue, and decreased appetite for certain foods. Most side effects are mild to moderate and decrease over time as your body adjusts. PlexusDx clinical staff monitors you throughout treatment and adjusts your plan if side effects become problematic.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.